Blaise Coleman - Endo International CEO President
0Y5F Stock | 629.53 9.30 1.50% |
CEO
Blaise Coleman is CEO President of Endo International PLC
Age | 50 |
Address | Minerva House, Dublin, Ireland, 4 |
Phone | 353 1 268 2000 |
Web | https://www.endo.com |
Endo International Management Efficiency
The company has return on total asset (ROA) of 0.0443 % which means that it generated a profit of $0.0443 on every $100 spent on assets. This is way below average. Endo International's management efficiency ratios could be used to measure how well Endo International manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Endo International's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 5.6 B in 2024, whereas Other Assets are likely to drop 0.95 in 2024.Similar Executives
Found 5 records | CEO Age | ||
Matthew CFA | Jupiter Fund Management | 49 | |
AnnaCarin Grandin | Coor Service Management | 57 | |
ASA GrdCerMinEcon | Neometals | 50 | |
Roderick Lockhart | Lendinvest PLC | 44 | |
Sebastiaan Berger | Ceiba Investments | N/A |
Management Performance
Return On Asset | 0.0443 |
Endo International PLC Leadership Team
Elected by the shareholders, the Endo International's board of directors comprises two types of representatives: Endo International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endo. The board's role is to monitor Endo International's management team and ensure that shareholders' interests are well served. Endo International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endo International's outside directors are responsible for providing unbiased perspectives on the board's policies.
Susan Williamson, Senior Officer | ||
James MD, Executive Development | ||
Frank Raciti, Controller VP | ||
Tracy Basso, Chief Officer | ||
Blaise Coleman, CEO President | ||
Laure Park, Senior Affairs | ||
Cheryl Stouch, Senior Officer | ||
Mark Bradley, Executive CFO | ||
Patrick Barry, Executive Operations | ||
Matthew Maletta, Chief VP |
Endo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Endo International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | 0.0443 | ||||
Profit Margin | (1.22) % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 7.41 B | ||||
Shares Outstanding | 224.34 M | ||||
Shares Owned By Insiders | 0.65 % | ||||
Shares Owned By Institutions | 0.21 % | ||||
Revenue | 2.01 B | ||||
Gross Profit | 1.29 B | ||||
EBITDA | 692.88 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Endo Stock Analysis
When running Endo International's price analysis, check to measure Endo International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endo International is operating at the current time. Most of Endo International's value examination focuses on studying past and present price action to predict the probability of Endo International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endo International's price. Additionally, you may evaluate how the addition of Endo International to your portfolios can decrease your overall portfolio volatility.